Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

Author： Bautzováá Tereza Rabišškováá Miloslava Lamprecht Alf

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.37, Iss.9, 2011-09, pp. : 1100-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiparticulate Systems in the Treatment of Inflammatory Bowel Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 137-144

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 5, 2013-10 ,pp. : 328-340

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M. Klotz U.

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite